Together, these results demonstrate that Se@BSA NPs can modulate GPx‐1 levels, thereby suppressing NLRP3 inflammasome activation and providing a therapeutic effect in IRI‐induced AKI. The gene discussed is NLRP3; the disease is acute kidney injury.